GANULAMERAN
UNII I74C16KK3J

Substance Identification & Data

This profile provides standardized clinical and technical data for Ganulameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I74C16KK3J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2433844-55-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
I74C16KK3J
CAS Registry Number
2433844-55-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GANULAMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11890
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ganulameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GANULAMERAN

Common Names & Synonyms

GANULAMERAN [INN]
GANULAMERAN [WHO-DD]
RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN S1S2 SECRETORY SIGNAL PEPTIDE PLUS RECEPTOR-BINDING DOMAIN FUSION PROTEIN WITH T4 FIBRITIN FOLDON DOMAIN FUSION PROTEIN WITH SPIKE GLYCOPROTEIN S1S2 TRANSMEMBRANE DOMAIN-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER BNT162B3), INNER SALT

Technical Codes

BNT162B3
BNT-162B3